Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new combination therapy for the most aggressive form of medulloblastoma, a fast growing type of pediatric brain cancer. The study was published online today in Cancer Cell, and is expected to lead to a clinical trial to confirm the benefits of the novel drug combination.
↧